Library

feed icon rss

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
  • 1
    Electronic Resource
    Electronic Resource
    Springer
    Naunyn-Schmiedeberg's archives of pharmacology 279 (1973), S. 93-97 
    ISSN: 1432-1912
    Keywords: Catechol-O-Methyltransferase ; Monoamine Oxidase ; Erythrocyte
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Notes: Summary Catecholamine inactivating enzymes in red blood cells are preferentially localized in the reticulocytes and not in mature erythrocytes: catechol-O-methyltransferase (COMT) activity in erythrocyte ghost preparations from reticulocyte-rich blood of rats pretreated with acetyl-phenylhydrazine was found to be 5 times higher than in ghosts from reticulocyte-poor blood. In the respective 12000×g supernates of the haemolysates, COMT activity in reticulocyte-rich preparations was not significantly enhanced. Significant monoamine oxidase (MAO) activity was only found in ghosts from reticulocyte-rich blood prepared by centrifugation at 12000×g. MAO activity was inhibited in vitro by pargyline concentrations〈10−6 M. These results are in agreement with earlier findings which have shown that rat reticulocytes contain a complete adrenergic β-receptor-effector system.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 2
    Electronic Resource
    Electronic Resource
    Springer
    Naunyn-Schmiedeberg's archives of pharmacology 273 (1972), S. 27-42 
    ISSN: 1432-1912
    Keywords: Monoamine Oxidase ; Irreversible Enzyme Inhibition ; Rates of Recovery from Inhibition ; Enzyme Protein Turnover ; Tranylcypromine
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Notes: Summary 1. After irreversible inhibition of monoamine oxidase (MAO) in rats with hydrazine derivatives (3-amino-2-oxazolidinone, furazolidone, benmoxine) and the non-hydrazine pargyline, recovery of enzyme activity occurred at rates which were characteristic for the organ investigated and independent of the chemical structure of the irreversible inhibitor. The respective half times were the same in homogenates and in mitochondria and amounted to about 10 days in the brain and 3 to 4 days in the liver; in the small intestine, mucosal MAO activity recovered with a half time of 0.5 days, whereas in the residual intestinal layers a half time of about 4 days was found.\3-Tranylcypromine is not an irreversible inhibitor: the half times of MAO recovery were 3.6 days in the brain and 2.4 days in the liver. Thus, long duration of inhibition and organ-specific half times of recovery of MAO inhibition are characteristic features of irreversible inhibitors. 2. When mitochondrial protein was labelled by i.v. injection of 14C-leucine, specific radioactivity declined with a half time of 9.4 days in the brain and 4.0 days in the liver; for the intestinal mucosa and for the residual intestinal layers, a half time of 0.5 and 4.4 days, respectively, was found. As these values are nearly identical with those found for the rates of MAO recofery after irreversible inhibition, the assumption is supported that irreversibly inhibited MAO must be replaced by newly synthetized enzyme. Vice versa, the rates of MAO recovery after irreversible inhibition seem to reflect the rates of mitochondrial protein turnover. Measurements of the rate of recovery of irreversibly inhibited MAO activity may therefore be useful to determine the turnover of the enzyme protein.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 3
    ISSN: 1432-1912
    Keywords: Tetrahydropapaveroline Derivatives ; Amine/Aldehyde Condensation ; Monoamine Oxidase ; β-Sympathomimetics ; Tetrahydropapaverolinderivate ; Amin/Aldehyd-Kondensation ; Monoaminoxydase ; β-Sympathicomimetica
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Description / Table of Contents: Zusammenfassung 1. Bei der Inkubation von Monoaminoxydase-haltigen Präparationen (Mitochondrien aus Meerschweinchenleber) mit den blutdrucksteigernden Aminen α-Methyldopamin und Tyramin entsteht eine blutdrucksenkende (Ratte, Katze) und am Herzvorhof (Meerschweinchen) positiv inotrop wirkende Substanz. Das β-Sympathicolyticum Pronethalol antagonisierte beide Wirkungen kompetitiv. 2. Das säulenchromatographisch isolierte β-Sympathicomimeticum erwies sich als ein Kondensationsprodukt aus α-Methyldopamin und dem durch oxydative Desaminierung von Tyramin in den Inkubaten entstandenen p-Hydroxyphenylacetaldehyd. Es war identisch mit dem aus synthetisch hergestelltem p-Hydroxyphenylacetaldehyd (Hydraminspaltung von Synephrin) durch Kondensation mit α-Methyldopamin erhaltenen 3′-Desoxy-3-methyl-tetrahydropapaverolin (DM-THP). Der Identitätsbeweis wurde mit chromatographischen, infrarot-spektrometrischen und pharmakologischen Methoden geführt. 3. DM-THP war am Herzvorhof etwa 6mal, am Blutdruck etwa 100mal schwächer β-adrenergisch wirksam als Tetrahydropapaverolin, das in analoger Weise durch Kondensation von Dopamin mit 3,4-Dihydroxyphenylacetaldehyd entsteht. 4. Beziehungen zwischen chemischer Konstitution und β-sympathicomimetischer Wirksamkeit werden diskutiert.
    Notes: Summary 1. A substance which lowered the blood pressure of the rat and the cat and had an inotropic action on the guinea pig auricle was formed when monoamine oxidase preparations (mitochondria from guinea pig liver) were incubated with the pressor amines α-methyldopamine and tyramine. Both actions were competetively antagonised by the β-receptor blocking drug pronethalol. 2. The compound which acts on β-receptors was isolated from the incubates (column chromatography) and found to be formed from α-methyldopamine by condensation with p-hydroxyphenylacetaldehyde, the aldehyde formed from tyramine by oxidative deamination. The condensation product proved to be identical with synthetic 3′-deoxy-3-methyl-tetrahydropapaveroline (DM-THP) obtained from α-methyldopamine by interaction with authentic p-hydroxyphenylacetaldehyde. The aldehyde was synthesized from synephrine by hydramine cleavage. The identification was made by means of chromatographic, infrared spectrometric and pharmacological methods. 3. When compared with tetrahydropapaveroline, DM-THP was 6 times weaker in its inotropic action and 100 times weaker as a hypotensive agent. 4. The relationship between chemical configuration and β-receptor stimulating activity was discussed.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 4
    Electronic Resource
    Electronic Resource
    Springer
    European journal of clinical pharmacology 23 (1982), S. 15-20 
    ISSN: 1432-1041
    Keywords: amezinium ; sympathomimetic effects ; catecholamines ; echocardiography ; systolic time intervals ; orthostatic stress ; inhibition of noradrenaline uptake
    Source: Springer Online Journal Archives 1860-2000
    Topics: Chemistry and Pharmacology , Medicine
    Notes: Summary The cardiovascular effects of the sympathomimetic agent amezinium were investigated in a double-blind, placebo-controlled, randomized trial in six volunteers. Before and 2 h after oral administration of amezinium 30 mg or placebo the cardiovascular responses to orthostatic stress, induced by 80° passive head-up tilt, were assessed by recording blood pressure, systolic time intervals, and echocardiogram. Plasma catecholamines were also determined. After amezinium treatment, the average supine systolic blood pressure was increased by +30 mm Hg and after tilting it remained above both the pre-treatment and placebo values. Compared to placebo, amezinium elicited only minor changes in heart rate and diastolic blood pressure. The effect of amezinium on the pre-ejection period corrected for heart rate (PEPc) and mean velocity of fiber shortening (VCFmean) indicated positive inotropic properties. Its effects were distinctly more pronounced during tilt than with the subjects supine. Plasma concentrations of noradrenaline and adrenaline were not influenced by amezinium during rest or tilt. From these results and previous research it is concluded that amezinium induces its sympathomimetic effects by preferentially inhibiting the re-uptake of noradrenaline which is released by the drug itself, or by sympathetic activation during tilt. This mechanism of action might explain the pronounced sympathomimetic effects of the drug, especially during orthostatic stress.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 5
    ISSN: 1432-1041
    Keywords: Prenylamine in man ; catecholamines ; urinary metabolites ; cardiovascular effects ; directly and indirectly acting sympathomimetics
    Source: Springer Online Journal Archives 1860-2000
    Topics: Chemistry and Pharmacology , Medicine
    Notes: Summary The effect of prenylamine on the cardiovascular effects of intravenously infused directly and indirectly acting sympathomimetic amines was investigated in 5 healthy volunteers. — 1. After oral administration of 180 mg/day prenylamine for 9 days, the pressor effect of the indirect sympathomimetic tyramine (3 mg/min over 6 min) was markedly diminished. — 2. Under the same experimental conditions the rise in blood pressure after i.v. infusion of 15 µg/min noradrenaline and 30 µg/min adrenaline, resp., for 6 min, was significantly increased. — 3. Treatment for 9 days with prenylamine produced a relative prolongation of the pressor effects of noradrenaline and adrenaline. Prolongation of the pressor action of the indirectly acting sympathomimetic tyramine was also observed despite a diminution in its maximum pressor effect. — 4. The urinary excretion of catecholamines (noradrenaline plus adrenaline) and their 0-methylated derivatives was significantly enhanced during the administration of prenylamine. Excretion of 3-methoxy-4-hydroxyphenylglycol decreased, whereas vanilmandelic acid and 5-hydroxyindole acetic acid excretion were not significantly affected. — 5. These results are compatible with the assumption that prenylamine in therapeutic doses interferes mainly with the sympathomimetic amine transport mechanisms located in the cytoplasmic membranes of sympathetic nerves and other cells. Our results do not support the assumption of a reserpine-like action of this drug in man.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 6
    Electronic Resource
    Electronic Resource
    Springer
    Naunyn-Schmiedeberg's archives of pharmacology 265 (1970), S. 397-410 
    ISSN: 1432-1912
    Keywords: Monoamine Oxidase ; MAO Inhibitors ; Nitrofurans ; Hydrazines ; Enzyme Inhibition (Irreversible)
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Notes: Summary Four bacteriostatically active nitrofurfurylidene compounds and their respective hydrazine moieties were administered to male Wistar rats. MAO activity was measured in vivo by different methods in liver, brain, and small intestine. Inhibition of DAO activity was determined in small intestine of rats and, in in-vitro experiments, in a partially purified pig kidney enzyme preparation. 1. Only those nitrofuran derivatives, which contain a hydrazine moiety that also inhibited the enzyme, were MAO inhibitors. The same was true for DAO; both enzymes were inhibited irreversibly. It is concluded that a hydrazine derivative with a free NH2-group as produced by metabolic transformation of the parent compound must be responsible for the amine oxidase inhibiting action of nitrofuran derivatives in vivo. Thus, both N-(5-nitro-2-furfurylidene)-3-amino-2-oxazolidinone and 3-amino-2-oxazolidinone were MAO inhibitors, the latter being 30–60 times more potent. K-(5-nitro-2-furfurylidene)-3-amino-5-methylmercaptomethyl-2-oxazolidinone was not an MAO inhibitor, although 3-amino-5-methylmercaptomethyl-2-oxazolidinone did inhibit the enzyme. In this case, the parent compound is possibly not metabolized to an active substance. In regard to 5-nitro-2-furfurylidene-4-hydroxybenzoyl-hydrazide and N-(5-nitro-2-furfurylidene)-1-amino-hydantoin, both the parent compounds and their respective hydrazine moieties-4-hydroxybenzoyl-hydrazide and 1-amino-hydantoin-were not inhibitors of MAO. 2. The steepness of the dose-response curves of MAO inhibition decreased in the order brain-liver-small intestine. These differences are explained by different turnover rates of enzyme protein as reflected by different half-life times of enzyme reactivation in the respective organs (10, 3, and 1.8 days for brain, liver, and small intestine, respectively). Consequently, duration and also degree of an irreversible MAO inhibition depend not only on the local concentration of the inhibiting drug, but also on the rate of protein turnover in the respective organ. It is stated that, inter alia, accordance between enzyme reactivation rate and enzyme protein turnover rate is a criterion for an irreversible MAO inhibitor.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...